SEC Stock Promotion Scheme Charges Against the Cannabis Industry
In October, the United States Securities and Exchange Commission (SEC) announced that it would be charging two (2) cannabis companies, Emerald Health and HighTimes, and six (6) associated individuals who worked with the companies, for their involvement in “stock promotion schemes.” Stock promotion schemes are “fraudulent schemes to promote the securities of issuers that were […]
SEC Stock Promotion Scheme Charges Against the Cannabis Industry Read More »


































